The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: Results of a noninferiority, randomized, phase IIIb trial

  1. Batista, J.E.
  2. Kölbl, H.
  3. Herschorn, S.
  4. Rechberger, T.
  5. Cambronero, J.
  6. Halaska, M.
  7. Coppell, A.
  8. Kaper, M.
  9. Huang, M.
  10. Siddiqui, E.
Aldizkaria:
Therapeutic Advances in Urology

ISSN: 1756-2880,  1756-2872

Argitalpen urtea: 2015

Alea: 7

Zenbakia: 4

Orrialdeak: 167-179

Mota: Artikulua

DOI: 10.1177/1756287215589250 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus